NL-OMON51218
已完成
不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19 - SAVID
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Franciscus Gasthuis & Vlietland
- 入组人数
- 150
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
Trial ended prematurely
研究者
入排标准
入选标准
- •18 years of age or older;
- •admitted to the COVID\-19 cohort ward of the Franciscus Gasthuis \&
- •Vlietland hospital for (suspicion of) SARS\-CoV\-2 infection;
- •written informed consent.
排除标准
- •undergoing experimental interventions for COVID\-19;
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19NL-OMON20323Board of Directors Franciscus Gasthuis & Vlietland350
招募中
2 期
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
已完成
不适用
The Diagnostic and Prognostic Role of SAA in Intrathoracic SarcoidosisSarcoidosis, PulmonaryNCT05811962University Medical Centre Ljubljana135
Unknown
不适用
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial PeritonitisSpontaneous Bacterial PeritonitisNCT02759497Tanta University100
已完成
不适用
Prospective study on evaluation of amyloid accumulation in patients suspected of both cerebral amyloid angiopathy and isolated cortical venous thrombosis using Amyloid positron emission tomographycerebral amyloid angiopathy isolated cortical venous thrombosisJPRN-UMIN000037101Kohnan Hospital4